STOWERS INSTITUTE FOR MEDICAL RESEARCH: Form 990, tax year 2024

View the entire original 990 at ProPublica ↗

Organization
STOWERS INSTITUTE FOR MEDICAL RESEARCH (EIN 20-2993509)
Tax period
2024-07-01 to 2025-06-30
Filed
2026-05-12
IRS object ID
202611329349302761
Schema version
2024v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2026-05-12T09:49:28+00:00ReturnTs
Tax Period End2025-06-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN440160260PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1Forvis Mazars LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line11201 Walnut Street Suite 1700AddressLine1Txt
CityKansas CityCityNm
State AbbreviationMOStateAbbreviationCd
ZIP641062246ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2024-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN202993509EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1STOWERS INSTITUTE FOR MEDICAL RESEARCHBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlSTOWBusinessNameControlTxt
Phone8169264000PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11000 EAST 50TH STREETAddressLine1Txt
CityKANSAS CITYCityNm
State AbbreviationMOStateAbbreviationCd
ZIP64110ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonJonathan ThomasPersonNm
Person TitleChairPersonTitleTxt
Signature2026-05-12SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonMichael EnglePreparerPersonNm
PTINP00482834PTIN
Phone8162216300PhoneNum
Preparation2026-05-12PreparationDt
FieldValueIRS element (for citing)
Tax2024TaxYr
Build TS2025-03-06 01:10:19ZBuildTS

Form 990 IRS990

Principal Ofcr Business Name PrincipalOfcrBusinessName

FieldValueIRS element (for citing)
Business Name Line1JONATHAN THOMASBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line11000 EAST 50TH STREETAddressLine1Txt
CityKANSAS CITYCityNm
State AbbreviationMOStateAbbreviationCd
ZIP64110ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$198,952,261GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.STOWERS.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2005FormationYr
Legal Domicile StateDELegalDomicileStateCd
Activity Or MissionSTOWERS INSTITUTE FOR MEDICAL RESEARCH'S ("SIMR") EXEMPT PURPOSE IS TO PERFORM MEDICAL RESEARCH IN THE PUBLIC INTEREST WITH THE GOAL OF EXPANDING OUR UNDERSTANDING OF THE FUNDAMENTAL PROCESSES OF LIVING CELLS.ActivityOrMissionDesc
Voting Members Governing Body8VotingMembersGoverningBodyCnt
Voting Members Independent2VotingMembersIndependentCnt
Total Employee360TotalEmployeeCnt
Total Volunteers2TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
PY Contributions Grants$101,275,805PYContributionsGrantsAmt
CY Contributions Grants$99,681,043CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$141,574PYInvestmentIncomeAmt
CY Investment Income$2,263,801CYInvestmentIncomeAmt
PY Other Revenue$6,080,685PYOtherRevenueAmt
CY Other Revenue$66,668CYOtherRevenueAmt
PY Total Revenue$107,498,064PYTotalRevenueAmt
CY Total Revenue$102,011,512CYTotalRevenueAmt
PY Grants And Similar Paid$3,171,598PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$83,105CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$41,542,860PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$43,117,143CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$67,456,764PYOtherExpensesAmt
CY Other Expenses$61,487,905CYOtherExpensesAmt
PY Total Expenses$112,171,222PYTotalExpensesAmt
CY Total Expenses$104,688,153CYTotalExpensesAmt
PY Revenues Less Expenses-$4,673,158PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$2,676,641CYRevenuesLessExpensesAmt
Total Assets BOY$186,739,928TotalAssetsBOYAmt
Total Assets EOY$179,349,437TotalAssetsEOYAmt
Total Liabilities BOY$18,815,931TotalLiabilitiesBOYAmt
Total Liabilities EOY$17,159,864TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$167,923,997NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$162,189,573NetAssetsOrFundBalancesEOYAmt
MissionTHE INSTITUTE'S MISSION IS TO MAKE A SIGNIFICANT CONTRIBUTION TO HUMANITY THROUGH MEDICAL RESEARCH BY EXPANDING OUR UNDERSTANDING OF THE SECRETS OF LIFE AND BY IMPROVING LIFE'S QUALITY THROUGH INNOVATIVE APPROACHES TO THE CAUSES, TREATMENT, AND PREVENTION OF DISEASES.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$61,473,097ExpenseAmt
Grant$83,105GrantAmt
Revenue$0RevenueAmt
DescSIMR'S ACCOMPLISHMENTS ARE DESCRIBED IN SCHEDULE O.Desc
Total Program Service Expenses$61,473,097TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesfalseLobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (true)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtfalseIndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesfalseForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesfalseFundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Escrow AccountfalseEscrowAccountInd
On Behalf Of IssuerfalseOnBehalfOfIssuerInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemYes (true)BusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityYes (true)RelatedEntityInd
Related Organization Ctrl EntYes (true)RelatedOrganizationCtrlEntInd
Transaction With Control EntYes (true)TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgYes (true)TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document35IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee360EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsfalseQuidProQuoContributionsInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtYes (true)SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members8GoverningBodyVotingMembersCnt
Independent Voting Member2IndependentVotingMemberCnt
Family Or Business RlnYes (true)FamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Policies Reference ChaptersfalsePoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherfalseCompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
Written Policy Or ProcedurefalseWrittenPolicyOrProcedureInd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1KATY GRAHAMBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone8169264000PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11000 E 50TH STREETAddressLine1Txt
CityKANSAS CITYCityNm
State AbbreviationMOStateAbbreviationCd
ZIP64110ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (16 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeInd
ALEJANDRO SNCHEZ ALVARADO
DIR/PRESIDENT/CHIEF SCIENTIFIC OFFICER40.04.0Yes (X)Yes (X)$1,094,951$0$839,779
CHARLES GERMAN
DIRECTOR/SECRETARY2.047.0Yes (X)Yes (X)$0$1,165,721$80,585
JONATHAN THOMAS
DIRECTOR/CHAIR BEGINNING OF SERVICE 3/24/252.015.0Yes (X)Yes (X)$0$0$0
RICHARD W BROWN
DIRECTOR/CHAIR DECEASED 3/27/252.047.0Yes (X)Yes (X)$0$3,103,954$102,383
ALBERZINE FREEMAN
DIRECTOR2.04.0Yes (X)$0$0$0
BRENT KREIDER
DIRECTOR2.042.0Yes (X)$0$787,292$91,449
DAVID A WELTE
DIRECTOR2.07.0Yes (X)$0$0$0
GEORGE L SATTERLEE
DIRECTOR2.040.0Yes (X)$0$518,670$84,947
KAUSIK SI
DIRECTOR40.02.0Yes (X)$780,244$0$241,908
BRIAN SLAUGHTER
VP OF SCIENTIFIC OPERATIONS40.00.0Yes (X)$337,739$0$86,285
PENNY M SPENCE
CFO THRU 4/8/20252.049.0Yes (X)$0$753,782$79,650
JENNIFER GERTON
INVESTIGATOR40.02.0$396,972$0$87,876Yes (X)
JERRY L WORKMAN
INVESTIGATOR40.00.0$359,953$0$80,748Yes (X)
MATTHEW C GIBSON
INVESTIGATOR40.08.0$407,200$0$238,318Yes (X)
R SCOTT HAWLEY
INVESTIGATOR DECEASED 1/31/2540.00.0$360,706$0$76,835Yes (X)
ROBERT E KRUMLAUF
SCIENTIFIC DIRECTOR EMERITUS40.00.0$1,859,563$0$82,041Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$5,597,328TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$6,329,419TotReportableCompRltdOrgAmt
Total Other Compensation$2,172,804TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K63IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (4 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
ELECTRICAL CORPORATION OF AMERICA
PO BOX 18070RAYTOWNMO64133Electrical Services$719,885
UNIVERSITY OF TEXAS
SOUTHWESTERN MEDICAL CENTERDALLASTX75390Collaboration Expense$253,068
CORNELL UNIVERSITY
DIV OF FINANCIAL AFFAIRSITHACANY14851Collaboration Expense$217,312
P1 CONSTRUCTION LLC
13605 W 96TH TERRLENEXAKS66215Construction Services$185,998
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K4CntrctRcvdGreaterThan100KCnt
Related Organizations$93,168,857RelatedOrganizationsAmt
Government Grants$5,707,124GovernmentGrantsAmt
All Other Contributions$805,062AllOtherContributionsAmt
Noncash Contributions$93,000,000NoncashContributionsAmt
Total Contributions$99,681,043TotalContributionsAmt

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$0TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,484,617TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$1,484,617ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$20,000TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$20,000ExclusionAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Less Rental Expenses LessRentalExpensesGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$97,292,568SecuritiesAmt
Other$427,365OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$96,569,928SecuritiesAmt
Other$370,821OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$722,640SecuritiesAmt
Other$56,544OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$779,184TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$779,184ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$0FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$0ContriRptFundraisingEventAmt
Fundraising Direct Expenses$0FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$0GrossSalesOfInventoryAmt
Cost Of Goods Sold$0CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescOTHER REBATES AND REVENUEDesc
Business900099BusinessCd
Total Revenue Column$46,668TotalRevenueColumnAmt
Exclusion$46,668ExclusionAmt

Miscellaneous Revenue MiscellaneousRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$46,668OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$102,011,512TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$2,330,469ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$83,105TotalAmt
Program Services$83,105ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$4,058,774TotalAmt
Program Services$3,652,897ProgramServicesAmt
Management And General$405,877ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$694,029TotalAmt
Program Services$624,626ProgramServicesAmt
Management And General$69,403ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$28,135,496TotalAmt
Program Services$25,321,946ProgramServicesAmt
Management And General$2,813,550ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$3,557,541TotalAmt
Program Services$3,201,787ProgramServicesAmt
Management And General$355,754ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$4,699,744TotalAmt
Program Services$4,229,770ProgramServicesAmt
Management And General$469,974ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,971,559TotalAmt
Program Services$1,774,403ProgramServicesAmt
Management And General$197,156ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$133,308TotalAmt
Program Services$0ProgramServicesAmt
Management And General$133,308ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt
Fundraising$0FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$403,525TotalAmt
Program Services$363,173ProgramServicesAmt
Management And General$40,352ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$153,803TotalAmt
Program Services$138,423ProgramServicesAmt
Management And General$15,380ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$202,444TotalAmt
Program Services$182,200ProgramServicesAmt
Management And General$20,244ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$9,000TotalAmt
Program Services$9,000ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$128,140TotalAmt
Program Services$115,326ProgramServicesAmt
Management And General$12,814ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,042,411TotalAmt
Program Services$938,170ProgramServicesAmt
Management And General$104,241ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$718,924TotalAmt
Program Services$647,032ProgramServicesAmt
Management And General$71,892ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$9,827,625TotalAmt
Program Services$9,827,625ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
COST SHARING W/ RELATED ORG$38,393,080$0$38,393,080$0
LAB SUPPLIES$6,550,185$6,550,185$0$0
PER CAPITA APPROP. TO GSSIMR$2,805,150$2,805,150$0$0
SEC. 4960 EXCISE TAX$510,581$459,523$51,058$0

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$609,729TotalAmt
Program Services$548,756ProgramServicesAmt
Management And General$60,973ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$104,688,153TotalAmt
Program Services$61,473,097ProgramServicesAmt
Management And General$43,215,056ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$791,947BOYAmt
EOY$720,822EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$887,588BOYAmt
EOY$799,194EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$3,290EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$10,501BOYAmt
EOY$8,620EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$154,605BOYAmt
EOY$133,985EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$343,167,995LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$221,841,137LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$126,920,728BOYAmt
EOY$121,326,858EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$47,930,044BOYAmt
EOY$48,855,978EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$6,706,957BOYAmt
EOY$6,871,103EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$3,337,558BOYAmt
EOY$629,587EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$186,739,928BOYAmt
EOY$179,349,437EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$9,116,526BOYAmt
EOY$8,047,293EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$261,384BOYAmt
EOY$253,388EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$9,438,021BOYAmt
EOY$8,859,183EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$18,815,931BOYAmt
EOY$17,159,864EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$167,666,903BOYAmt
EOY$161,991,400EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$257,094BOYAmt
EOY$198,173EOYAmt

Cap Stk Tr Prin Current Funds CapStkTrPrinCurrentFundsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Pd In Cap Srpls Land Bldg Eqp Fund PdInCapSrplsLandBldgEqpFundGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Rtn Earn Endowment Incm Oth Fnds RtnEarnEndowmentIncmOthFndsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$167,923,997BOYAmt
EOY$162,189,573EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$186,739,928BOYAmt
EOY$179,349,437EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$2,676,641ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$371,900NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts-$2,685,883DonatedServicesAndUseFcltsAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredYes (true)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (true)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Medical Research OrganizationYes (X)MedicalResearchOrganizationInd

Hospital Name And Address HospitalNameAndAddressGrp

Supported Organization Name SupportedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1UNIVERSITY OF KANSAS MEDICAL CENTERBusinessNameLine1Txt
FieldValueIRS element (for citing)
CityKANSAS CITYCityNm
State AbbreviationKSStateAbbreviationCd

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule A, Part I, Line 4 MEDICAL RESEARCH HOSPITAL AFFILIATIONFormAndLineReferenceDesc
ExplanationCooperation Agreements and Collaborations Since October 2000, the Stowers Institute has maintained a cooperative relationship and agreement with Children's Mercy Kansas City. The Stowers Institute conducts medical research in conjunction with the University of Kansas (KU) and its affiliates the University of Kansas Hospital Authority and the University of Kansas Medical Center (KUMC), pursuant to a written memorandum of understanding. KUMC is the academic health science center for the largest public research university in the state of Kansas. KUMC offers programs and services that focus on education, research, patient care, and community engagement. As of June 30, 2025, five KUMC students have received M.S. degrees and 53 KUMC students have received Ph.D. degrees for thesis work performed in Stowers Institute labs. KUMC is affiliated with the University of Kansas Health System, a nonprofit independent hospital system co-located with the main KUMC campus in Kansas City, Kansas. During July 2024 - June 2025, 15 Stowers research program leaders served as adjunct faculty in three KUMC departments. These appointments included 11 full professors and four assistant professors. Thirty-five of the Stowers Institute's 54 original research publications included both Stowers Institute and KUMC affiliations. Seven KUMC students performed predoctoral research in Stowers labs. The Stowers Institute is also a consortium member of the University of Kansas Cancer Center at KUMC, a cancer research and care partnership spanning two states and involving collaboration among researchers, physicians, and cancer support professionals in foundational, translational, and clinical research areas. In June 2012, the NIH's National Cancer Institute (NCI) named the University of Kansas Cancer Center an NCI-Designated Cancer Center, part of a pillar of federal cancer research efforts and integral to the NCI's programs for studying, treating, and preventing cancer. In 2022, the NCI named the University of Kansas Cancer Center an NCI-Designated Comprehensive Cancer Center - the highest honor bestowed by the NCI, the only such center in the region, and one of only 57 centers in the United States. During July 2024 - June 2025, eight Stowers research program leaders were members of the University of Kansas Cancer Center's Cancer Biology Research Program, including Stowers Investigator Linheng Li, Ph.D., who serves as co-leader of the program. During July 2024 - June 2025, Stowers Investigator Linheng Li, Ph.D., continued a collaboration with the University of Kansas Cancer Center and Children's Mercy Kansas City to investigate approaches to treat leukemia. This research focuses on targeting cancer stem cells to help reduce the recurrence of cancer after a patient enters into remission. The collaboration builds on foundational research from the Li Lab that has characterized cancer stem cells at molecular and cellular levels, has produced peer-reviewed scientific publications, and is related to a Children's Mercy clinical research study. During July 2024 - June 2025, the Stowers Institute conducted research in conjunction with the private, nonprofit Marine Biological Laboratory (MBL), an affiliate of the University of Chicago located in Woods Hole, Massachusetts. Since 1888, the MBL has hosted thousands of researchers, students, and faculty from all over the world to fulfill its mission of scientific discovery by exploring fundamental biology, understanding biodiversity and the environment, and informing the human condition through research and education. Since 2022, a Lease Agreement with the MBL provides the Stowers Institute a dedicated, year-round laboratory on the MBL campus and access to services and resources such as shared research and equipment rooms, a shared microscopy facility, and the Marine Resources Center, a highly advanced facility for maintaining, culturing, and providing aquatic organisms. During July 2024 - June 2025, Stowers Institute scientists collaborated with researchers at 164 national and international institutions including dozens of hospitals, medical centers, and medical schools. Many of these collaborations resulted in discoveries that merited publication in leading peer-reviewed scientific journals and/or successfully funded grant awards. The Stowers Institute participated in research collaborations in conjunction with the following US hospitals and research institutions, pursuant to an understanding to maintain continuing close cooperation in the active conduct of medical research during July 2024 - June 2025: Boston Children's Hospital; Boston University; Carnegie Institution for Science; Carnegie Mellon University; Children's Mercy Hospital; Children's Mercy Research Institute; City of Hope National Medical Center; Clemson University; Cleveland Clinic; Cornell University; Duke University Medical Center; Florida Atlantic University; Fred Hutchinson Cancer Center; Harvard Medical School; Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Kansas University Medical Center; Lehigh University; Loyola University Chicago; Massachusetts Institute of Technology; MD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Morgridge Institute for Research; Murdoch Children's Research Institute; New York University; North Carolina Central University; Northwestern University; Northwestern University Feinberg School of Medicine; Oregon Health Sciences University; Oregon National Primate Research Center; Penn State University; Philadelphia University; Rice University; San Diego Biomedical Research Institute; Stony Brook University; Texas A&M University; The Broad Institute of MIT and Harvard; The Children's Hospital of Philadelphia; The Jackson Laboratory for Genomic Medicine; Ohio State University School of Medicine; Rockefeller University; University at Albany; University of California, Berkeley; University of California, Irvine; University of California, Riverside; University of California, San Diego; University of California, Santa Barbara; University of California, Santa Cruz; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; University of Connecticut; University of Georgia; University of Kansas; University of Kansas Medical Center; University of Kentucky; University of Louisville; University of Maryland; University of Miami; University of Michigan; University of Minnesota; University of Missouri; University of Missouri-Kansas City; University of New Hampshire; University of Pennsylvania; University of Pittsburgh; University of Southern California; University of Tennessee Health Science Center; University of Washington; University of Washington and Seattle Children's Hospital; University of Washington School of Medicine; University of Wisconsin-Madison; University of Wisconsin-Madison School of Medicine and Public Health; Washington University School of Medicine; Washington University St. Louis School of Medicine; Westlake University; Yale School of Medicine; Yale School of Public Health.ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$257,094BeginningYearBalanceAmt
Contributions$199,303ContributionsAmt
Other Expenditures$258,224OtherExpendituresAmt
End Year Balance$198,173EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$270,078BeginningYearBalanceAmt
Contributions$70,285ContributionsAmt
Other Expenditures$83,269OtherExpendituresAmt
End Year Balance$257,094EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$429,239BeginningYearBalanceAmt
Contributions$1,000ContributionsAmt
Other Expenditures$160,161OtherExpendituresAmt
End Year Balance$270,078EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$259,722BeginningYearBalanceAmt
Contributions$266,944ContributionsAmt
Other Expenditures$97,427OtherExpendituresAmt
End Year Balance$429,239EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$209,007BeginningYearBalanceAmt
Contributions$61,060ContributionsAmt
Other Expenditures$10,345OtherExpendituresAmt
End Year Balance$259,722EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.0BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.0PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY1.0TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd

Land LandGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$3,400,000OtherCostOrOtherBasisAmt
Book Value$3,400,000BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$239,638,498OtherCostOrOtherBasisAmt
Depreciation$147,235,743DepreciationAmt
Book Value$92,402,755BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$98,957,978OtherCostOrOtherBasisAmt
Depreciation$74,605,394DepreciationAmt
Book Value$24,352,584BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$1,171,519OtherCostOrOtherBasisAmt
Depreciation$0DepreciationAmt
Book Value$1,171,519BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$121,326,858TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (6 entries)

DescDescAmtAmt
Federal Income Taxes
ADVANCES FROM AFFILIATES$3,891,867
PAYABLE TO GSSIMR
COMPENSATION EXCISE TAX$719,480
OPERATING LEASE LIABILITY$199,751
DEFERRED COMP LIABILITY$4,048,085
FieldValueIRS element (for citing)
Total Liability$8,859,183TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Other Revenue$0OtherRevenueAmt
Revenue Not Reported$0RevenueNotReportedAmt
Revenue Subtotal$0RevenueSubtotalAmt
Other Revenues Not Included$0OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$0TotalRevenuePerForm990Amt
Other Expenses Included$0OtherExpensesIncludedAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$0ExpensesSubtotalAmt
Other Expenses Not Included$0OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$0TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule D, Part V, Line 4 Intended uses of endowment fundsTHE ENDOWMENT IS COMPRISED OF DONATIONS FOR THREE SPECIFIC PURPOSES. THE FIRST PURPOSE IS TO ESTABLISH A LECTURE SERIES PROGRAM WHERE SIMR HOSTS SCIENCE SPEAKERS FROM OTHER RESEARCH INSTITUTIONS AND UNIVERSITIES TO ENCOURAGE COLLABORATIVE SCIENCE OPPORTUNITIES WITH TOP SCIENTISTS FROM AROUND THE WORLD. THE SECOND PURPOSE IS TO SUPPORT A SPECIFIC SIMR LAB THAT STUDIES REGENERATION. THE THIRD PURPOSE IS TO SUPPORT STUDENT PAYMENT FOR THE ACADEMIC YEAR.
Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnoteFIN 48 FINANCIAL STATEMENT FOOTNOTE FROM THE CONSOLIDATED STATEMENTS OF STOWERS INSTITUTE FOR MEDICAL RESEARCH (THE INSTITUTE) IS AS FOLLOWS: THE INSTITUTE RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. RECOGNIZED INCOME TAX POSITIONS ARE MEASURED AT THE LARGEST AMOUNT THAT IS GREATER THAN 50% LIKELY OF BEING REALIZED.

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable

Recipient Business Name RecipientBusinessName

FieldValueIRS element (for citing)
Business Name Line1STOWERS REAL ESTATE HOLDING CORPORATIONBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line11000 EAST 50TH STREETAddressLine1Txt
CityKANSAS CITYCityNm
State AbbreviationMOStateAbbreviationCd
ZIP64110ZIPCd
FieldValueIRS element (for citing)
Recipient EIN261472230RecipientEIN
IRC Section501(C)(2)IRCSectionDesc
Non Cash Assistance$83,105NonCashAssistanceAmt
Valuation Method UsedNET BOOK VALUEValuationMethodUsedDesc
Non Cash AssistanceLEASEHOLD IMPROVEMENTSNonCashAssistanceDesc
Purpose Of GrantSIMR PROVIDED SREHC, A RELATED PARTY AS DISCLOSED IN SCHEDULE R, WITH LEASEHOLD IMPROVEMENTS TO ASSIST IN SREHC'S EXEMPT PURPOSE.PurposeOfGrantTxt
FieldValueIRS element (for citing)
Total501c3 Org0Total501c3OrgCnt
Total Other Org1TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule I, Part I, Line 2 Procedures for monitoring use of grant fundsFormAndLineReferenceDesc
ExplanationSIMR'S EXEMPT PURPOSE IS TO PERFORM MEDICAL RESEARCH IN THE PUBLIC INTEREST WITH THE GOAL OF EXPANDING OUR UNDERSTANDING OF THE FUNDAMENTAL PROCESSES OF LIVING CELLS. THE SUPPORT INCLUDES, BUT IS NOT LIMITED TO DISTRIBUTING LEASEHOLD IMPROVEMENTS TO SREHC IN FUTHERANCE OF ITS EXEMPT PURPOSE. SREHC IS A RELATED TAX-EXEMPT ORGANIZATION OF SIMR, AS DESCRIBED IN SCHEDULE R, PART II.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Club Dues Or FeesYes (X)ClubDuesOrFeesInd
Written Policy Ref T And E ExpnssYes (true)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (true)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (true)SupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgYes (true)CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (13 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
ALEJANDRO SNCHEZ ALVARADO
DIR/PRESIDENT/CHIEF SCIENTIFIC OFFICER$1,041,927$0$0$0$53,024$0$771,447$0$68,332$0$1,934,730$0$0$0
RICHARD W BROWN
DIRECTOR/CHAIR DECEASED 3/27/25$0$3,054,433$0$0$0$49,521$0$51,750$0$50,633$0$3,206,337$0$0
CHARLES GERMAN
DIRECTOR/SECRETARY$0$1,146,011$0$0$0$19,710$0$51,750$0$28,835$0$1,246,306$0$0
KAUSIK SI
DIRECTOR$777,922$0$0$0$2,322$0$203,265$0$38,643$0$1,022,152$0$0$0
BRENT KREIDER
DIRECTOR$0$773,792$0$0$0$13,500$0$51,750$0$39,699$0$878,741$0$0
GEORGE L SATTERLEE
DIRECTOR$0$515,106$0$0$0$3,564$0$51,750$0$33,197$0$603,617$0$0
PENNY M SPENCE
CFO THRU 4/8/2025$0$752,972$0$0$0$810$0$51,750$0$27,900$0$833,432$0$0
BRIAN SLAUGHTER
VP OF SCIENTIFIC OPERATIONS$336,929$0$0$0$810$0$51,462$0$34,823$0$424,024$0$0$0
MATTHEW C GIBSON
INVESTIGATOR$385,417$0$0$0$21,783$0$203,265$0$35,053$0$645,518$0$0$0
ROBERT E KRUMLAUF
SCIENTIFIC DIRECTOR EMERITUS$355,160$0$0$0$1,504,403$0$51,750$0$30,291$0$1,941,604$0$0$0
JERRY L WORKMAN
INVESTIGATOR$355,762$0$0$0$4,191$0$51,750$0$28,998$0$440,701$0$0$0
R SCOTT HAWLEY
INVESTIGATOR DECEASED 1/31/25$355,762$0$0$0$4,944$0$51,750$0$25,085$0$437,541$0$0$0
JENNIFER GERTON
INVESTIGATOR$342,650$0$0$0$54,322$0$51,750$0$36,126$0$484,848$0$0$0

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule J, Part I, Line 1a First-class or charter travelSIMR PAID FOR FIRST-CLASS TRAVEL FOR JERRY WORKMAN IN ONE INSTANCE. THIS INDIVIDUAL WAS NOT TAXED ON THE BENEFIT SINCE THE TRAVEL WAS FOR BUSINESS PURPOSES.
Schedule J, Part I, Line 1a Health or social club dues or initiation feesSIMR HAS A WRITTEN EMPLOYMENT AGREEMENT WITH ALEJANDRO SANCHEZ ALVARADO, WHICH PROVISIONS INCLUDE REIMBURSEMENT FOR PROFESSIONAL AND SOCIAL CLUB DUES. ALL TAXABLE BENEFITS ARE TREATED AS COMPENSATION TO THE RECEIPIENT.
Schedule J, Part I, Line 4b Supplemental nonqualified retirement planThe following individuals participated in a supplemental nonqualified retirement plan ALEJANDRO SANCHEZ ALVARADO - ACCRUAL OF $719,697 AND $0 DISTRIBUTION. KAUSIK SI - ACCRUAL OF $151,515 AND $0 DISTRIBUTION. MATTHEW C. GIBSON - ACCRUAL OF $151,515 AND $0 DISTRIBUTION.
Schedule J, Part I, Line 5a Compensation contingent on revenues of the organizationSIMR MADE A PAYMENT OF $1,501,313 TO ROBERT E. KRUMLAUF, SCIENTIFIC DIRECTOR. THIS PAYMENT REPRESENTS THE PORTION OF THE NET ROYALTIES RECEIVED BY SIMR FOR LICENSED SCIENTIFIC DISCOVERY TECHNOLOGY THAT IS PAYABLE TO ROBERT E. KRUMLAUF, PH.D., FOR HIS PARTICIPATION IN THE DISCOVERY.

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1TATJANA PIOTROWSKI PHDBusinessNameLine1Txt
FieldValueIRS element (for citing)
Relationship DescriptionSEE PART VRelationshipDescriptionTxt
Transaction$336,551TransactionAmt
TransactionEMPLOYEE OF SIMRTransactionDesc
Sharing Of RevenuesfalseSharingOfRevenuesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule L, Part IV LINE 1FormAndLineReferenceDesc
ExplanationTATJANA PIOTROWSKI, PH.D, IS THE SPOUSE OF ALEJANDRO SANCHEZ ALVARADO, CHIEF SCIENTIFIC OFFICER OF SIMR. MS. PIOTROWSKI IS AN INVESTIGATOR AT SIMR. HER PREVIOUS EMPLOYMENT BEFORE SIMR WAS WITH THE UNIVERSITY OF UTAH'S SCHOOL OF MEDICINE WHERE SHE WAS AN ASSOCIATE PROFESSOR IN THE DEPARTMENT OF NEUROBIOLOGY AND ANATOMY.ExplanationTxt

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Contribution2ContributionCnt
Noncash Contributions Rpt F990$93,000,000NoncashContributionsRptF990Amt
Method Of Determining RevenuesMarket valueMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Form8283 Received0Form8283ReceivedCnt
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule M, Part I Column B - Number of ContributionsFormAndLineReferenceDesc
ExplanationThe amounts shown in Part I, Column (B) for "Number of Contributions" represents the total number of contributions.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (10 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Form 990, Part III, Line 4a PROGRAM SERVICE DESCRIPTIONJuly 2024 - June 2025 Program Service Accomplishments The Stowers Institute for Medical Research ("Stowers Institute "Institute") is a private, nonprofit medical research organization. The Institute was founded in 1994 by Jim and Virginia Stowers, who each survived a bout with cancer and subsequently dedicated their fortune to supporting fundamental and multidisciplinary research addressing biological questions that will provide novel insights and long-term solutions to human diseases. The Stowers Institute conducts fundamental biomedical research aimed at advancing our understanding of the intricate molecular and cellular mechanisms that govern life. By investigating genes, proteins, and biological processes, scientists at the Stowers Institute explore how cells proliferate, differentiate into various tissues and organs, regenerate, and undergo programmed cell death. This comprehensive approach to studying cellular and organismal biology provides crucial insights into the underlying causes of numerous diseases, including cancer, birth defects, and neurodegenerative disorders. Historically, such foundational research has proven to be the cornerstone for developing novel therapeutic strategies, preventive measures, and potential cures for a wide range of human ailments. The Institute's commitment to foundational research not only advances scientific knowledge but also lays the groundwork for future medical breakthroughs that can significantly impact human health. July 2024 - June 2025 Notable Research Results During July 2024 - July 2025, Stowers Institute research teams made discoveries meriting publication in leading peer-reviewed scientific journals - 54 original research papers in all. Stowers Institute research teams also produced 11 other publications including reviews, commentaries, book chapters, and books. Some of the highlights among these papers and other advances involving Stowers Institute research include the following: The Bazzini Lab discovered strategies for how dengue and hundreds of other viruses replicate in their hosts, with the potential to aid in developing novel antiviral treatments and vaccines. Published in Molecular Systems Biology on July 22, 2024, the study revealed that the dengue virus genome uses less efficient codons than its host to make its own proteins using the host's machinery to replicate and spread. The Sanchez Alvarado Lab unveiled a critical timing factor involved in regulating regeneration. Published in iScience on September 20, 2024, the study sought to understand exactly how an organism knows how much tissue has been lost post-injury. The team investigated how African killifish properly regrow their tail fin following damage. By analyzing tissue dynamics during regrowth, they found that in addition to known factors, including how many cells are participating and where they are located, the length of time cells spend engaged in the repair process is also key. Research from the Piotrowski lab uncovered a process cued by environmental changes that drives zebrafish sensory organ development, a mechanism with the potential to provide resilience to climate change. Published in Development on October 22, 2024, the study discovered how precursor cells to neuromast ionocytes can sense specific components in their surroundings that cause them to mature. These ions are key components that transmit electrical signals and regulate water pressure within and between cells, tissues, and organs. Most animals' body mass largely consists of water, making these ion-sensing cells important. A study from the Zanders lab revealed how the lethal pathogenic fungus, Cryptococcus neoformans, thrives, allowing them to identify potential novel therapeutic targets for treatment. Published in PLoS BIOLOGY on June 5, 2025, the study refined a genetic tool to identify which genes in C. neoformans are essential for its survival. Importantly, the research team uncovered more than 1,400 required genes, including more than 300 that share no similarity with human genes, making them promising targets for new antifungal drugs with reduced risks for side effects. Comprehensive Lists of Original Research Papers, Reviews, Commentaries, Chapters, and Books Published July 2024 - June 2025 Original Research Papers 1. RAP proteins regulate apicoplast noncoding RNA processing in Plasmodium falciparum. Hollin T, Chahine Z, Abel S, Banks C, Pasaje CFA, Lenz T, Prudhomme J, Ybanez CM, Abbaszadeh AS, Niles JC, Florens L, Le Roch KG. Cell Reports. 2025 Jun 27; j.celrep.2025.115928 2. Embryology 2024: a summer like no other. Abshire KM, Dagher L, Espinoza F, Gupta A, Hammond JE, Lion AT, Merkuri F, Miao Y, Neiro J, Pahima M, Prabhakara C, Sonpho EK, Styfhals R, Trani Bustos M, Zimmer F. Development. 2025 Jun 1; 152. 3. Multinucleated giant cells are hallmarks of ovarian aging with unique immune and degradation-associated molecular signatures. Converse A, Perry MJ, Dipali SS, Isola JVV, Kelly EB, Varberg JM, Zelinski MB, Stout MB, Pritchard MT, Duncan FE. PloS Biology. 2025 Jun 23; 10.1242/dev.204908. 4. Landscape of essential growth and fluconazole-resistance genes in the human fungal pathogen Cryptococcus neoformans. Billmyre RB, Craig CJ, Lyon JW, Reichardt C, Kuhn AM, Eickbush MT, Zanders SE. PloS Biology. 2025 May 22; e3003184. 5. Analysis of FAIMS for the study of affinity-purified protein complexes using the orbitrap ascend tribrid mass spectrometer. Goswami P, Cesare J, Rekowski MJ, Clark Z, Thornton J, Washburn MP. Molecular Omics. 2025 May 20. 6. ZNF574 is a Quality Control Factor for Defective Ribosome Biogenesis Intermediates. Akers JF, LaScola M, Bothe A, Suh H, Jung C, Stolp ZD, Ghosh T, Yan LL, Wang Y, Macurak M, Devan A, McKinney MC, Grismer TS, Reyes AV, Ross EJ, Hu T, Xu S-L, Ban N, Kostova KK. Molecular Cell. 2025 May 7. 7. Autonomous follicle quality control mechanisms: Innate immune signaling capabilities of granulosa cells. Hashim PH, Perry MJ, Pritchard MT, Gerton JL, Duncan FE. Reproduction. 2025 May 1; 169: e250042. 8. An atypical basement membrane forms a midline barrier during left-right asymmetric gut development in the chicken embryo. Demler C, Lawlor JC, Yelin R, Llivichuzcha-Loja D, Shaulov L, Kim D, Stewart M, Lee FK, Shylo N, Trainor PA, Schultheiss TM, Kurpios NA. eLife. 2025 April 29. 9. Bottom-up reconstruction of functional death fold signalosomes reveals a requirement for polymer stability and avidity. Lichtenstein MA, Cao F, Lobnow F, Dirvanskyte P, Weyhenmeyer D, Kulesza A, Ziska E, Halfmann R, Taylor MJ. Science. 2025 April 24. 10. Pre-oviposition development of the brown anole (Anolis sagrei). Weberling A, Shylo NA, Kircher BK, Wilson H, McClain M, Marchini M, Starr K, Sanger T, Hollfelder F, Trainor P. Developmental Dynamics. 2025 April 17. 11. Reproductive Adaptation of Astyanax mexicanus Under Nutrient Limitation. Xia F, Santacruz A, Wu D, Bertho S, Fritz E, Morales-Sosa P, McKinney S, Nowotarski SH, Rohner N. Developmental Biology. 2025 April 14. 12. Complete sequencing of ape genomes. Yoo D, Rhie A, Hebbar P, Antonacci F, Logsdon GA, Solar SJ, Antipov D, Pickett BD, Safonova Y, Montinaro F, Luo Y, Malukiewicz J, Storer JM, Lin J, Sequeira AN, Mangan RJ, Hickey G, Monfort Anez G, Balachandran P, Bankevich A, Beck CR, Biddanda A, Borchers M, Bouffard GG, Brannan E, Brooks SY, Carbone L, Carrel L, Chan AP, Crawford J, Diekhans M, Engelbrecht E, Feschotte C, Formenti G, Garcia GH, de Gennaro L, Gilbert D, Green RE, Guarracino A, Gupta I, Haddad D, Han J, Harris RS, Hartley GA, Harvey WT, Hiller M, Hoekzema K, Houck ML, Jeong H, Kamali K, Kellis M, Kille B, Lee C, Lee Y, Lees W, Lewis AP, Li Q, Loftus M, Loh YHE, Loucks H, Ma J, Mao Y, Martinez JFI, Masterson P, McCoy RC, McGrath B, McKinney S, Meyer BS, Miga KH, Mohanty SK, Munson KM, Pal K, Pennell M, Pevzner PA, Porubsky D, Potapova T, Ringeling FR, Rocha JL, Ryder OA, Sacco S, Saha S, Sasaki T, Schatz MC, Schork NJ, Shanks C, Smeds L, Son DR, Steiner C, Sweeten AP, Tassia MG, Thibaud-Nissen F, Torres-Gonzalez E, Trivedi M, Wei W, Wertz J, Yang M, Zhang P, Zhang S, Zhang Y, Zhang Z, Zhao SA, Zhu Y, Jarvis ED, Gerton JL, Rivas-Gonzalez I, Paten B, Szpiech ZA, Huber CD, Lenz TL, Konkel MK, Yi SV, Canzar S, Watson CT, Sudmant PH, Molloy E, Garrison E, Lowe CB, Ventura M, O'Neill RJ, Koren S, Makova KD, Phillippy AM, Eichler EE. Nature. 2025 April 10; 641-8062. 13. Interpreting regulatory mechanisms of Hippo signaling through a deep learning sequence model. Dalal K, McAnany C, Weilert M, McKinney MC, Krueger S, Zeitlinger J. Cell Genomics; 5: 100821. 14. Investigating the Aggregation and Prionogenic Properties of Human Cancer-Related Proteins. Goncharoff D, Du Z, Venkatesan S, Cho B, Zhao J, Alasady MJ, Huey D, Ma H, Rosenthal J, Turenitsa A, Feldman C, Halfmann R, Mendillo ML, Li L. Molecular and Cellular Biology. 2025 March 31; 45:154.
Form 990, Part III, Line 4a PROGRAM SERVICE DESCRIPTION - CONT'D15. Identification and characterization of short-chain dehydrogenase/reductase 3 (DHRS3) deficiency, a retinoic acid embryopathy of humans. Hashimoto As, Yu J, Williams C, Zueckert-Gaudenz K, Varshosaz P, Zhao R, Pilli N, Liu TY, Russell J, Tooze RS, Twigg SRF, Banka S, Sweeney EW, McGowan SJ, Knight SJL, Taylor JC, Froukh TJ, Palafoll MIV, Martinez-Gil N, Costa-Roger M, Villarreal-Molina MT, Hernandez EL, Jamra RA, Gattermann F, Koch-Hogrebe M, Wieczorek D, Trainor PA, Moise AR, Wilkie AOM, Kane MA. Genetics in Medicine. 2025 March 29; 3: 103427. 16. Enhanced RNA-targeting CRISPR-Cas technology in zebrafish. Moreno-Sanchez I, Hernandez-Huertas L, Nahon-Cano D, Gomez-Marin C, Martinez-Garcia PM, Treichel AJ, Tomas-Gallardo L, da Silva Pescador G, Kushawah G, Diaz-Moscoso A, Cano-Ruiz A, Walker JA, 2nd, Munoz MJ, Holden K, Galceran J, Nieto MA, Bazzini A, Moreno-Mateos MA. Nature Communications. 2025 March 17. 17. Differentially expressed miRNAs offer new perspective into cave adaptation of Astyanax mexicanus. Biswas T, Rajendran N, Hassan H, Li H, Zhao C, Rohner N. Annual New York Academy of Science. 2025 March 14. 18. Highly Optimized Simulation of Atomic Resolution Cell-Like Protein Environment. Tytarenko AM, Singh A, Ambati VK, Copeland MM, Kundrotas PJ, Halfmann R, Kasyanov PO, Feinberg EA, Vakser IA. Journal of Physical Chemistry B. 2025 March 13; 129. 19. Chromatin remodeling protein BPTF mediates chromatin accessibility at gene promoters in planarian stem cells. Verma P, Allen JM, Sanchez Alvarado A, Duncan EM. BMC Genomics. 2025 March 12; 26. 20. Cell extrusion drives neural crest cell delamination. Moore E, Wood C, Zhao R, McKinney C, Yi K, Trainor P. Proceedings of the National Academy of Sciences U.S.A. 2025 March 10; 122: e2416566122. 21. Patterns of crossover distribution in Drosophila mauritiana necessitate a re-thinking of the centromere effect on crossing over. Hawley RS, Price A, Li H, Jagannathan M, Staber C, Hughes SE, Williams S, Perera A, Egidy RR, Lawlor A, Miller DE, Blumenstiel JP. Genetics. 2025 March 7. 22. Comparative analysis of neural crest development in the chick and mouse. Morrison JA, Pushel I, McLennan R, McKinney MC, Gogol MM, Scott A, Krumlauf R, Kulesa PM. Developmental Biology. 2025 March 1; 519. 23. DCLK1-mediated regulation of invadopodia dynamics and matrix metalloproteinase trafficking drives invasive progression in head and neck squamous cell carcinoma. Arnold L, Yap M, Farrokhian N, Jackson L, Barry M, Ly T, Arjunan P, Kaczorowski-Worthley A, Tews C, Pandey A, Morrison A, Washburn MP, Standing D, Gomez JP, Yellapu NK, Johnson D, Li L, Umar S, Anant S, Thomas SM. Molecular Cancer. 2025 Feb 25; 24. 24. Functional and evolutionary constraints of wtf killer meiotic drivers. Nidamangala Srinivasa A, Campell S, Venkatesan S, Nuckolls NL, Lange JJ, Halfmann R, Zanders S. PloS Genetics. 2025 Feb 18; 21: e1011534. 25. Population genomics of premature termination codons in cavefish with substantial trait loss. Roback EY, Ferrufino E, Moran RL, Shennard D, Mulliniks C, Gallop J, Weagley J, Miller J, Fily Y, Ornelas-Garcia CP, Rohner N, Kowalko JE, McGaugh SE. Mol Biol Evol. 2025 Feb 3; 42. 26. Real-time imaging reveals a role for macrophage protrusive motility in melanoma invasion. Ramakrishnan G, Miskolci V, Hunter M, Giese MA, Munch D, Hou Y, Eliceiri KW, Lasarev MR, White RM, Huttenlocher A. Journal of Cell Biology. 2025 Feb 3; 224. 27. SNORD113-114 cluster maintains haematopoietic stem cell self-renewal via orchestrating the translation machinery. Wang H, Zhang Z, Han C, Jiang P, Xu J, Han Y, Huang D, Li J, Zhou J, Durnin M, Chen S, Liu Y, Sheng J, Cao J, Liu J, Liu B, Yu J, Wang F, Qian P. Nature Cell Biology. 2025 Feb 1; 27. 28. Oogenesis involves a novel nuclear envelop remodeling mechanism in Schmidtea mediterranea. Guo L, Guo F, Zhang S, Zeng A, Yi K, McClain M, Kuhn CD, Parmely T, Sanchez Alvarado AS. Developmental Biology. 2025 Jan 23; 520. 29. Optimized smFISH Pipeline for Studying Nascent Transcription in Mouse Embryonic Tissue Samples. Afzal Z, Krumlauf R. Methods of Molecular Biology. 2025 Jan 2; 2889. 30. Torque-driven superparamagnetic microbots. Morozov KI, Zusmanovich D, Rubinstein B, Leshansky A. Physics of Fluids. 2025 Jan 2; 37: 12017. 31. Molecular, Cellular, and Developmental Organization of the Mouse Vomeronasal organ at Single Cell Resolution. Hills M, Jr., Ma L, Fang A, Chiremba T, Malloy S, Scott A, Perera A, Yu CR. eLife. 2024 Dec 11. 32. PfMORC protein regulates chromatin accessibility and transcriptional repression in the human malaria parasite, Plasmodium falciparum. Chahine Z, Gupta M, Lenz T, Hollin T, Abel S, Banks C, Saraf A, Prudhomme J, Bhanvadia S, Florens L, Le Roch KG. eLife. 2024 Dec 5. 33. Postprandial sleep in short-sleeping Mexican cavefish. Gallman K, Rastogi A, North O, O'Gorman M, Hutton P, Lloyd E, Warren W, Kowalko JE, Duboue ER, Rohner N, Keene AC. Journal of Experimental Zoology. Part A, Ecological and Integrative Physiology. 2024 Dec 2; 341. 34. Co-option of the trichome-forming network initiated the evolution of a morphological novelty in the evolution of a morphological novelty in Drosophila eugracilis. Rice, G. Current Biology. 2024 Nov 18; 34. 35. A powerful and versatile new fixation protocol for immunostaining and in situ hybridization that preserves delicate tissues. Guerrero-Hernandez C, Doddihal V, Mann FG, Jr., Sanchez Alvarado A. BMC Biology. 2025 Nov 5; 22. 36. C G composition in transposon-derived genes is increased in FXD with perturbed immune system. Suganuma T, Hassan H, Gogol M, Workman J. NAR Molecular Medicine. 2024 Oct 28; 1: ugae015. 37. Codon optimality influences homeostatic gene expression in zebrafish. DeVore, M. L. G3 (Bethesda). 2024 Oct 24. 38. Protein profiling of zebrafish embryos unmasks regulatory layers during early embryogenesis. da Silva Pescador G, Baia Amaral D, Varberg JM, Zhang Y, Hao Y, Florens L, Bazzini AA. Cell Reports. 2024 Oct 22; 43: 114769. 39. Distinct regions within SAP25 recruit O-linked glycosylation, DNA demethylation, and ubiquitin ligase and hydrolase activities to the Sin3/HDAC complex. Goswami P, Banks CAS, Thornton J, Bengs B, Sardiu ME, Florens L, Washburn MP. Journal of Proteome Researcg. 2024 Oct 22. 40. DYRK1A Interacts with the Tuberous Sclerosis Complex and Promotes mTORC1 Activity. Wang, P. eLife. 2024 Oct 22. 41. Chromatin remodeller Chd7 is developmentally regulated in the neural crest by tissue-specific transcription factors. Williams, R. M. PloS Biology. 2024 Oct 18; 22. 42. Environmental and molecular control of tissue-specific ionocyte differentiation in zebrafish. Peloggia, J. Development. 2024 Oct 15; 151: dev202809. 43. Zika virus non-coding RNAs antagonize antiviral responses by PKR-mediated translational arrest. Pallares HM, Gonzalez Lopez Ledesma MM, Oviedo-Rouco S, Castellano LA, Costa Navarro GS, Fernandez-Alvarez AJ, Dreiz MJ, Aldas-Bulos VD, Alvarez DE, Bazzini AA, Gamarnik AV. Nucleic Acids Research. 2024 Oct 14; 52. 44. Poly (A) binding protein 2 is critical for stem cell differentiation during regeneration in the planarian Schmidtea mediterranea. Mukundan N, Hariharan N, Sasidharan V, Lakshmanan V, Palakodeti D, Jamora C. Frontiers in Cell and Developmental Biology. 2024 Oct 8; 12. 45. A kalihinol analog disrupts apicoplast function and vesicular trafficking in P. falciparum malaria. Chahine Z, Abel S, Hollin T, Chung JH, Barnes GL, Daub ME, Renard I, Choi JY, Pratap V, Pal A, Alba-Argomaniz M, Banks C, Kirkwood J, Saraf A, Camino I, Castaneda P, Cuevas MC, De Mercado-Arnanz J, Fernandez-Alvaro E, Garcia-Perez A, Ibarz N, Viera-Morilla S, Prudhomme J, Joyner CJ, Bei AK, Florens L, Ben Mamoun C, Vanderwal CD, Le Roch KG. Science. 2024 Sept 27; 385: eadm7966. 46. Positional information modulates transient regeneration-activated cell states during vertebrate appendage regeneration. Ortega Granillo, A. iScience. 2024 Sept 20; 27: 110737. 47. Sugar assimilation underlying dietary evolution of Neotropical bats. Camacho J, Bernal-Rivera A, Pena V, Morales-Sosa P, Robb SMC, Russell J, Yi K, Wang Y, Tsuchiya D, Murillo-Garcia OE, Rohner N. Nature Ecology and Evolution. 2024 Aug 31; 8. 48. The deubiquitinase Usp7 in Drosophila melanogaster is required for synaptonemal complex maintenance. Lake, C. M. Proceedings of the National Academy of Sciences U.S.A. 2024 Aug 27; 121: e2409346121. 49. An Integrated Structural Model of the DNA Damage Responsive H3K4me3 Binding WDR76:SPIN1 Complex with the Nucleosome. Liu X, Zhang Y, Wen Z, Hao Y, Banks CAS, Cesar J, Bhattacharya S, Arvidekar S, Lange JJ, Xie Y, Garcia BA, Slaughter BD, Unruh JR, Viswanath S, Florens L, Workman J, Washburn MP. Proceedings of the National Academy of Sciences U.S.A. 2024 Aug 13; 121: e2318501121.
Form 990, Part III, Line 4a PROGRAM SERVICE DESCRIPTION - CONT'D50. Plasticity of the mitotic spindle in response to karyotype variation. Kunchala P, Varberg JM, O'Toole E, Gardner J, Smith SE, McClain M, Jaspersen SL, Hawley RS, Gerton JL. Current Biology. 2025 Aug 5. 51. Two decades on: Special issue on olfaction celebrating Axel and Buck's Nobel Prize. Forni PE, Yu CR. Genesis. 2024 Jul 26; 62: e23613. 52. Dengue virus preferentially uses human and mosquito non-optimal codons. Castellano LA, McNamara RJ, Pallares HM, Gamarnik AV, Alvarez DE, Bazzini AA. Molecular System Biology. 2024 Jul 23. 53. Regulators of rDNA array morphology in fission yeast. Cockrell AJ, Lange JJ, Wood C, Mattingly M, McCroskey SM, Bradford WD, Conkright-Fincham J, Weems L, Guo MS, Gerton JL. PLoS Genetics. 2024 Jul 5; 20: e1011331. 54. Quartz Crystal Microbalance Frequency Response to Discrete Adsorbates in Liquids. Leshansky AM, Rubinstein BY, Fouxon I, Johannsmann D, Sadowska M, Adamczyk Z. Analytical Chemistry. 2024 Jul 2; 96. Reviews, Commentaries, Chapters, Books 1. Multinucleated giant cells are hallmarks of ovarian aging with unique immune and degradation-associated molecular signatures. Converse A, Perry MJ, Dipali SS, Isola JVV, Kelly EB, Varberg JM, Zelinski MB, Stout MB, Pritchard MT, Duncan FE. PloS Biology. 2025 Jun 23; e3003204. 2. From conservation to adaptation: Understanding the Synaptonemal Complex's evolutionary dynamics. Williams S, Hawley RS. Current Opinions in Genetics and Development. 2025 Apr 16. 3. The ever-diversifying landscape of intra-genomic conflict. Levine MT, Zanders SE. Seminars in Cell Development and Biology. 2025 Mar 28. 4. The Society for Craniofacial Genetics and Developmental Biology 47th Annual Meeting. Trainor PA, Cox TC, Clouthier DE, Fantauzzo KA, Harris MP, Jeong J, Stottmann RW, Merrill AE. American Journal of Medical Genetics A. 2025 Mar 17. 5. Signaling by co-operative higher-order assembly formation: linking evidence at molecular and cellular levels. Kobe B, Nanson JD, Hoad M, Blumenthal A, Gambin Y, Sierecki E, Stacey KJ, Ve T, Halfmann R. Biochemistry Journal. 2025 Mar 5. 6. NCR peptides in plant-bacterial symbiosis: applications and importance. Guerra-Garcia FJ, Sankari S. Trends in Microbiology. 2025 Feb 3. 7. Killer meiotic drive executed by a single two-state poison-antidote protein. Zanders S, Smith GR. Proceedings of the National Academy of Sciences U.S.A. 2024 Dec 2. 8. The Stacking Cell Puzzle. Mir, M. Patterns. 2024 Sept 13. 9. Ribosomes unraveled: The path from variant to impact. Kostos P, Galligos A, Gerton JL. Cell Genomics. 2024 Sept 13. 10. Establishing Primary and Stable Cell Lines from Frozen Wing Biopsies for Cellular, Physiological, and Genetic Studies in Bats. Deng F, Morales-Sosa P, Bernal-Rivera A, Wang Y, Tsuchiya D, Javier JE, Rohner N, Zhao C, Camacho J. Current Protocols. 2024 Sept 4. 11. Unveiling the Role of Soil Microbes in Herbicide Degradation and Crop Protection. Sankari, S. Molecular and Plant-Microbe Interactions. 2024 Jul 29. Competitive Research Grant Funding & Research Awards ions The ability of Stowers Institute scientists to receive competitively awarded research funding attests to the high level of research productivity taking place at the Institute. During July 2024 - June 2025, Stowers Institute scientists worked with the support of 30 grants and fellowships from the National Institutes of Health, one fellowship from the National Science Foundation, one grant from the Hearing Health Foundation, one fellowship from the Burroughs Wellcome Fund, one grant from BioNexus KC, two fellowships from the Howard Hughes Medical Institute, one grant from the Chan Zuckerberg Initiative, one grant from the Swiss National Science Foundation, one grant from the Leverhulme Trust, one fellowship from the American Society of Hematology, one fellowship from the Helen Hay Whitney Foundation, one fellowship from Klingenstein Philanthropies, one fellowship from Jane Coffin Childs Memorial Fund, one fellowship from the Marine Biological Laboratory, one fellowship from the Institute of Molecular Genetics of the Czech Academy of Sciences, and three grants from the University of Kansas Cancer Center. Support from new and continuing awards to the Stowers Institute totaled more than $6.3 million during July 2024 - June 2025 to supplement income from its endowments. Students are also encouraged to apply for fellowships where eligible. Our grants office provides guidance on fellowship deadlines and eligibility requirements and assists in preparation and submission. Testifying to the high level of achievement taking place at the Stowers Institute are the awards and honors Stowers Institute members received during July 2024 - June 2025: - Anna Galligos, received a 2024 National Institutes of Health Predoctoral Fellowship NRSA (F31) - Leo Yan, PhD, received a 2024 Jane Coffin Childs (JCC) Memorial Fund Fellowship - Blanka Mrazkova, PhD, received a 2024 Institute of Molecular Genetics of the Czech Academy of Sciences (IMG) Fellowship - Neet zel, PhD, received a 2024 Klingenstein-Simons Fellowship Award in Neuroscience - Jorge Moreno, PhD, received a 2025 Helen Hay Whitney Foundation Fellowship - Ekasit Sonpho, PhD, received a 2025 Marine Biological Laboratory Whitman Fellowship Award - Riley Galton, PhD, received a 2025 Howard Hughes Medical Institute Hanna H. Gray Fellowship - Laurence Florens, PhD, received a 2025 National Institutes of Health R01 subaward in collaboration with Karine Le Roch at University of California Riverside - Laurence Florens, PhD, received a 2025 National Institutes of Health R01 subaward in collaboration with Ke Hu at Arizona State University - Jerry Workman, PhD, was elected to the National Academy of Sciences in 2025 Independent Research Program Leaders Laboratories Individual scientists at the Stowers Institute perform fundamental biomedical research by studying research organisms, tissues, and cells to understand the molecular mechanisms underlying human health and disease. A comprehensive list of principal investigators from July 2024 to June 2025 follows: - Alejandro Sanchez Alvarado, Ph.D., President and Chief Scientific Officer, joined the Stowers Institute in 2011 from the University of Utah's School of Medicine, where he held the H.A. & Edna Benning Professorship of Neurobiology and Anatomy. He received a B.S. in molecular biology and chemistry from Vanderbilt University in Nashville, Tennessee, and a Ph.D. in pharmacology and cell biophysics from the University of Cincinnati College of Medicine in Cincinnati, Ohio. Sanchez Alvarado was appointed as a Howard Hughes Medical Institute Investigator in 2005 and is presently an Investigator Emeritus since 2022. Research focus: Molecular and cellular mechanisms underpinning animal regeneration using the planarian Schmidtea mediterranea and other research organisms. - Ariel Bazzini, Ph.D., Associate Investigator, joined the Stowers Institute in 2016 from the lab of Antonio J. Giraldez, Ph.D., in the Department of Genetics at Yale University, where he completed a postdoctoral fellowship. Bazzini received his Ph.D. in molecular biology at the University of Buenos Aires, Argentina. For his doctoral dissertation, he studied plant genetics at the Institute of Biotechnology in Argentina's National Institute of Agricultural Technology (INTA). Research focus: Regulation of gene expression in vertebrates. - Jennifer Gerton, Ph.D., Investigator, joined the Stowers Institute in 2002 from a postdoctoral fellowship in the lab of Joseph DeRisi, Ph.D., in the Department of Biochemistry and Biophysics at the University of California, San Francisco. Gerton received a Ph.D. in microbiology and immunology from Stanford University. Research focus: Genomic and genetic analysis of chromosome segregation and chromosome dynamics. - Matthew Gibson, Ph.D., Investigator and Dean of the Graduate School, joined the Stowers Institute in 2006 from a Jane Coffin Childs Memorial Fund postdoctoral fellowship with Norbert Perrimon, Ph.D., at Harvard Medical School. Gibson received a Ph.D. in zoology from the University of Washington. Research focus: Genetic analysis of mechanisms controlling signal transduction, cell proliferation, and epithelial morphogenesis during fruit fly, sea anemone, and coral development.
Form 990, Part III, Line 4a PROGRAM SERVICE DESCRIPTION - CONT'D- Randal Halfmann, Ph.D., Associate Investigator, joined the Stowers Institute in 2015 from the University of Texas Southwestern Medical Center. He received a Ph.D. in biology from the Massachusetts Institute of Technology, where he was a National Science Foundation Predoctoral Fellow. After completing his graduate studies, Halfmann obtained an independent position at UT Southwestern Medical Center where he was a Sara and Frank McKnight Fellow and received a Director's Early Independence Award from the National Institutes of Health. Research focus: Cellular and evolutionary implications of protein self-assembly using genetic, biochemical, and cell-biological approaches. - R. Scott Hawley, Ph.D., Investigator and Dean Emeritus of the Graduate School, joined the Stowers Institute in 2001 from the University of California, Davis where he was a professor of genetics in the Molecular and Cellular Biology section. Hawley earned a Ph.D. in genetics from the University of Washington and completed postdoctoral training as a Helen Hay Whitney Fellow at the Institute for Cancer Research in Philadelphia. Research focus: Investigation of mechanisms that influence how chromosomes pair and segregate during meiosis using Drosophila as an experimental system. Hawley passed away on January 31, 2025. - Robert Krumlauf, Ph.D., Scientific Director Emeritus and Investigator, joined the Stowers Institute in 2000 from England's National Institute for Medical Research, The Ridgeway, Mill Hill, London, where he was head of the Division of Developmental Neurobiology. Krumlauf received a Ph.D. in developmental biology from Ohio State University. Research focus: Analysis of molecular pathways that regulate how the mammalian head, brain and nervous system are built, using a variety of vertebrate research organisms. - Linheng Li, Ph.D., Investigator, joined the Stowers Institute in 2000 from the University of Washington Medical Center where he held a faculty appointment after completing postdoctoral training in the lab of Leroy Hood, M.D., Ph.D. Li earned his Ph.D. in molecular and cellular biology from New York University Medical School under the mentorship of Edward Ziff, Ph.D. Research focus: Investigation of molecular and genetic pathways controlling adult stem cell development in the hematopoietic and intestinal systems using transgenic and gene targeting animal model approaches. - Ameya Mashruwala, Ph.D., Assistant Investigator, joined the Stowers Institute in 2024 from Princeton University where he was a postdoctoral researcher in the lab of Bonnie Bassler, Ph.D. Mashruwala received his master's degree in biochemistry from Utah State University and his Ph.D. in microbial biology from Rutgers University in the lab of Jeffrey Boyd, Ph.D. Research focus: Understanding the development and function of bacterial communities. - Neet zel, Ph.D., Assistant Investigator, joined the Stowers Institute in 2023 from New York University where he was a postdoctoral fellow in the lab of Claude Desplan, Ph.D. zel earned a Ph.D. in neuroscience from the University of Texas Southwestern Medical Center in the lab of Robin Hiesinger, Ph.D. Research focus: Combining genetics, imaging, single-cell genomics, and computational modeling approaches to understand the fundamental molecular mechanisms that control brain development in the fruit fly. - Tatjana Piotrowski, Ph.D., Investigator, joined the Stowers Institute in 2011 from the University of Utah's School of Medicine, where she was an associate professor in the Department of Neurobiology and Anatomy. She received her master's degree from the University of Tubingen, Germany, and her Ph.D. from the Max Planck Institute for Developmental Biology in Tubingen. Research focus: Collective cell migration, cell type specification, and stem cell biology in zebrafish as a research system. - Siva Sankari, Ph.D., Assistant Investigator, joined the Stowers Institute in 2023 from the Massachusetts Institute of Technology where she was a postdoctoral research scientist in the lab of Graham Walker Ph.D. Sankari received a Ph.D. in biochemistry from the State University of New York at Buffalo. Research focus: Mechanisms of action of host-secreted peptides and how they act on symbiotic bacteria which may provide important clues to decipher the fundamental biology of host-microbe interactions. - Tatjana Sauka-Spengler, Ph.D., Investigator, joined the Stowers Institute in 2022 from the Weatherall Institute of Molecular Medicine at the University of Oxford, United Kingdom, where she continues to hold a professor position. Sauka-Spengler earned a Ph.D. in physics and a Ph.D. in biology from the University of Paris and completed postdoctoral training in the lab of Marianne Bronner, Ph.D., at the California Institute of Technology. Research focus: Decoding the gene regulatory networks involved in cell function of the neural crest, heart, and nervous system to uncover the mechanisms underpinning inflammation and regeneration and how they have evolved. - Kausik Si, Ph.D., Scientific Director and Investigator, joined the Stowers Institute in 2005 from the lab of Eric Kandel, M.D., at Columbia University Center for Neurobiology and Behavior where he was a Jane Coffin Childs Fellow and a Francis Goelet Fellow in Neuroscience. Si earned a Ph.D. in molecular biology from the Albert Einstein College of Medicine. Research focus: Role of synaptic protein synthesis in information acquisition and memory storage. - Paul Trainor, Ph.D., Investigator, joined the Stowers Institute in 2001 from a research position at the National Institute for Medical Research at Mill Hill, London, where he completed postdoctoral training. Trainor has a Ph.D. in developmental biology from Children's Medical Research Institute at the University of Sydney, Australia. Research focus: Investigation of the interactions between distinct tissues in the body and their regulation during normal development to reveal pathways that regulate normal cranial and facial development. - Jerry Workman, Ph.D., Investigator, joined the Stowers Institute in 2003 from the Pennsylvania State University where he held the Paul Berg Professorship of Biochemistry and was an Associate Investigator of the Howard Hughes Medical Institute. Workman earned a Ph.D. in cell and molecular biology from the University of Michigan and completed postdoctoral training at Rockefeller University with Bob Roeder, Ph.D. Research focus: Study of the protein complexes that modify chromatin. - C. Ron Yu, Ph.D., Investigator, joined the Stowers Institute in 2005 from the lab of Richard Axel, M.D., at Columbia University Center for Neurobiology and Behavior where he held a National Institutes of Health Mentored Research Scientist Award from the National Institute of Mental Health. Yu earned his Ph.D. in molecular, cellular, and biophysical studies at Columbia University. Research focus: How olfactory sensory information is detected, integrated, and processed in the brain to influence specific innate behaviors. Yu departed the Institute on November 1, 2024, to join Case Western Reserve University as Chair of the Department of Neurosciences. - SaraH Zanders, Ph.D., Associate Investigator and Vice Dean of the Graduate School, joined the Stowers Institute in 2016 after completion of her postdoctoral training in basic sciences at the Fred Hutchinson Cancer Research Center (Fred Hutch) with support from a Pathway to Independence Award from the National Institutes of Health. Fred Hutch faculty members Harmit S. Malik, Ph.D., and Gerry Smith, Ph.D., advised her research on fertility, genome evolution, and the origin of new species. Zanders received her Ph.D. in genetics and development from Cornell University. Research focus: Effects of genetic conflicts caused by selfish genes that are embedded in eukaryotic genomes. - Julia Zeitlinger, Ph.D., Investigator, joined the Stowers Institute in 2007 from the lab of Richard Young, Ph.D., at the Whitehead Institute for Biomedical Research at Massachusetts Institute of Technology where she was the recipient of a long-term postdoctoral fellowship from the Human Frontier Science Program. Zeitlinger earned a Ph.D. in molecular biology from the European Molecular Biology Laboratory in Heidelberg, Germany. Research focus: Analysis of the gene regulatory networks underlying cellular differentiation.
Form 990, Part VI, Line 11b Review of form 990 by governing bodyTHE DATA AND INFORMATION NECESSARY TO PREPARE SIMR'S FORM 990 WAS COMPILED BY SIMR'S ACCOUNTING DEPARTMENT. FORVIS MAZARS, LLP, THE INSTITUTE'S EXTERNAL TAX PREPARERS, USED THIS INFORMATION TO PREPARE THE FORM 990. THE COMPLETED FORM 990, INCLUDING REQUIRED SCHEDULES, IS REVIEWED BY THE OFFICERS OF SIMR BEFORE IT IS FILED WITH THE IRS. AFTER THE PREPARATION AND REVIEW PROCESS DESCRIBED ABOVE, THE FORM 990, INCLUDING REQUIRED SCHEDULES, IS PROVIDED TO EACH VOTING MEMBER OF THE ORGANIZATION'S BOARD BEFORE IT IS FILED WITH THE IRS.
Form 990, Part VI, Line 12c Conflict of interest policySIMR HAS ADOPTED A "CONFLICTS OF INTEREST AND DIRECTOR INDEPENDENCE POLICY". EACH DIRECTOR, OFFICER, AND ALL OTHER PERSONS IN A POSITION TO EXERCISE SUBSTANTIAL INFLUENCE OVER DECISIONS OF SIMR ARE REQUIRED TO ANNUALLY COMPLETE AND SIGN A DISCLOSURE STATEMENT THAT IS PART OF THE POLICY. A COVERED PERSON MUST ALSO DISCLOSE THE EXISTENCE OF A POTENTIAL CONFLICT AND ALL MATERIAL FACTS TO THE GOVERNING BOARD AS SOON AS THE PERSON HAS KNOWLEDGE THAT A POTENTIAL CONFLICT MIGHT EXIST. PER THE POLICY, THE BOARD THEN REVIEWS THE DISCLOSURE TO DETERMINE WHETHER A CONFLICT EXISTS. AFTER THE COVERED PERSON MAKES THE RELEVANT DISCLOSURE, THEY ARE RECUSED AND MAY NOT PARTICIPATE IN THE DELIBERATIONS AND DECISIONS REGARDING THE TRANSACTION. SIMR CONDUCTS PERIODIC AND ADHOC REVIEWS OF TRANSACTIONS AND AGREEMENTS TO ENSURE THAT IT ENGAGES ONLY IN ACTIVITIES THAT ARE CONSISTENT WITH ITS TAX EXEMPT PURPOSE.
Form 990, Part VI, Line 15a Process to establish compensation of top management officialTHE COMPENSATION FOR ALEJANDRO SANCHEZ ALVARADO, PRESIDENT AND CHIEF SCIENTIFIC OFFICER, WAS ESTABLISHED PURSUANT TO THE PROCEDURES OF TREAS. REG. SECTION 53.4958-6, INCLUDING (1) REVIEW AND APPROVAL BY SIMR'S COMPENSATION COMMITTEE COMPRISED OF INDEPENDENT PERSONS, (2) RELYING ON COMPARABILITY DATA, INCLUDING DATA PREPARED BY A NATIONALLY KNOWN COMPENSATION CONSULTANT REGARDING COMPARABLE SALARY AND BENEFITS FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS, AND (3) CONTEMPORANEOUS DOCUMENTATION AND RECORD KEEPING OF THE DELIBERATION AND DECISIONS REGARDING THE COMPENSATION ARRANGEMENT. THIS PROCESS WAS LAST UNDERTAKEN IN 2021.
Form 990, Part VI, Line 19 Required documents available to the publicSIMR'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST.
FORM 990, PART VI, LINE 2 FAMILY/BUSINESS RELATIONSHIPS AMONGST INTERESTED PERSONSJONATHAN THOMAS, RICHARD W. BROWN (DECEASED MARCH 27, 2025), DAVID A. WELTE, BRENT KREIDER, CHARLES GERMAN, ALBERZINE FREEMAN, AND ALEJANDRO SANCHEZ ALVARADO, ALL DIRECTORS OF SIMR, HAVE A BUSINESS RELATIONSHIP. JONATHAN THOMAS, RICHARD W. BROWN (DECEASED MARCH 27, 2025), CHARLES GERMAN, BRENT KREIDER, AND ALBERZINE FREEMAN, DIRECTORS OF SIMR, AND PENNY M. SPENCE, OFFICER OF SIMR (THROUGH APRIL 8, 2025), HAVE A BUSINESS RELATIONSHIP. RICHARD W. BROWN (DECEASED MARCH 27, 2025), CHARLES GERMAN, GEORGE L. SATTERLEE AND BRENT KREIDER, DIRECTORS OF SIMR, AND PENNY M. SPENCE, OFFICER OF SIMR (THROUGH APRIL 8, 2025), HAVE A BUSINESS RELATIONSHIP.
FORM 990, PART VI, LINE 15B PROCESS TO ESTABLISH COMPENSATION OF OTHER OFFICERSCHARLES GERMAN, RICHARD W. BROWN (DECEASED MARCH 27, 2025), JONATHAN THOMAS (BEGINNING OF SERVICE MARCH 24, 2025), BRENT KREIDER, GEORGE L. SATTERLEE AND PENNY M. SPENCE (THROUGH APRIL 8, 2025) ARE COMPENSATED BY ONE OF THE RELATED ORGANIZATIONS LISTED IN SCHEDULE R FOR THE SERVICES PERFORMED IN THEIR OFFICIAL CAPACITY FOR THE RELATED ORGANIZATION.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (7 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdExempt Code SectionExemptCodeSectionTxtPublic Charity StatusPublicCharityStatusTxtBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtControlled OrganizationControlledOrganizationInd
STOWERS SCIENTIFIC EDUCATION INSTITUTE
1000 EAST 50TH STREETKANSAS CITYMO64110205916445SUPPORT ORGDE501(c)(3)Type ISIMRYes (true)
STOWERS RESOURCE MANAGEMENT INC
1000 EAST 50TH STREETKANSAS CITYMO64110412186719SUPPORT ORGDE501(c)(3)Type ISIMRYes (true)
BIOMED VALLEY CORPORATION
1000 EAST 50TH STREETKANSAS CITYMO64110743238244SUPPORT ORGDE501(c)(3)Type ISIMRYes (true)
STOWERS REAL ESTATE HOLDING CORPORATION
1000 EAST 50TH STREETKANSAS CITYMO64110261472230TITLE HOLDINGDE501(c)(2)SRMYes (true)
STOWERS POLICY INSTITUTE INC
1000 EAST 50TH STREETKANSAS CITYMO64110203270502SEE PART VIIDE501(c)(4)SIMRYes (true)
THE GRADUATE SCHOOL OF SIMR
1000 EAST 50TH STREETKANSAS CITYMO64110464588696EDUCATIONMO501(c)(3)2SIMRYes (true)
STOWERS INVESTMENT HOLDING CORPORATION
1000 EAST 50TH STREETKANSAS CITYMO64110920365628TITLE HOLDINGDE501(c)(2)SRMSPIYes (true)

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp

Related Organization Name RelatedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1BIOMED VALLEY DISCOVERIESINCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line14435 MAIN ST STE 550AddressLine1Txt
CityKANSAS CITYCityNm
State AbbreviationMOStateAbbreviationCd
ZIP64111ZIPCd
FieldValueIRS element (for citing)
EIN061646533EIN
Primary ActivitiesSEE PART VIIPrimaryActivitiesTxt
Legal Domicile StateDELegalDomicileStateCd

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1NABusinessNameLine1Txt
FieldValueIRS element (for citing)
Entity TypeC CorporationEntityTypeTxt
Controlled OrganizationYes (true)ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts RyltsYes (true)ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgYes (true)GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgYes (true)GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgfalseLoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth OrgfalseLoansOrGuaranteesFromOthOrgInd
Div Related OrganizationfalseDivRelatedOrganizationInd
Asset Sale To Other OrgfalseAssetSaleToOtherOrgInd
Asset Purchase From Other OrgfalseAssetPurchaseFromOtherOrgInd
Asset ExchangefalseAssetExchangeInd
Rental Of Facilities To Oth OrgfalseRentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth OrgYes (true)RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgfalsePerformOfServicesForOthOrgInd
Perform Of Services By Other OrgfalsePerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (true)SharingOfFacilitiesInd
Paid Employees SharingYes (true)PaidEmployeesSharingInd
Reimbursement Paid To Other OrgYes (true)ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgYes (true)ReimbursementPaidByOtherOrgInd
Transfer To Other OrgYes (true)TransferToOtherOrgInd
Transfer From Other OrgfalseTransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (8 entries)

Transaction TypeTransactionTypeTxtInvolvedInvolvedAmtMethod Of Amount DeterminationMethodOfAmountDeterminationTxt
BIOMED VALLEY DISCOVERIES INC
A$700MARKET VALUE
STOWERS REAL ESTATE HOLDING CORP
B$83,105NET BOOK VALUE
STOWERS RESOURCE MANAGEMENT INC
C$93,068,857MARKET VALUE
STOWERS REAL ESTATE HOLDING CORP
K$2,685,883MARKET VALUE
STOWERS RESOURCE MANAGEMENT INC
P$34,720,380COST REIMB
THE GRADUATE SCHOOL OF SIMR
P$655,749COST REIMB
BIOMED VALLEY DISCOVERIES INC
Q$258,819COST REIMB
THE GRADUATE SCHOOL OF SIMR
R$2,805,150MARKET VALUE

Supplemental Information Detail SupplementalInformationDetail (11 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule R, Part II, Column (b) PRIMARY ACTIVITYSTOWERS POLICY INSTITUTE INC'S. ("SPI") PRIMARY ACTIVITY IS TO PROMOTE INNOVATIVE AND ETHICAL BIOMEDICAL RESEARCH, THERAPIES AND CURES, AND TO ADVOCATE FOR A POLITICAL, ECONOMIC AND SOCIAL ENVIRONMENT THAT ADVANCES, FACILITATES, AND PROTECTS THAT RESEARCH AND THOSE THERAPIES AND CURES.
Schedule R, Part IV, Column (b) PRIMARY ACTIVITYBIOMED VALLEY DISCOVERIES, INC.'S ("BVD") PRIMARY ACTIVITY IS THE DEVELOPMENT AND MARKETING OF SCIENTIFIC DISCOVERIES. BIOMED VALLEY CORPORATION ("BVC") IS THE 100% OWNER OF BVD STOCK.
Schedule R, Part V Line 2 - Type A - SUBLEASE PAYMENTS RECEIVEDSIMR RECEIVES SUBLEASE PAYMENTS FROM BVD BASED ON COST FOR LESS THAN 300 SQ FT OF SPACE FOR A LIMITED USE PURPOSE. THE ACTIVITY OF BVD WOULD NOT HAVE BEEN UNRELATED BUSINESS INCOME IF BVD WERE EXEMPT UNDER 501(C)(3) AND HAD THE SAME EXEMPT PURPOSE AS SIMR. THEREFORE, NO PORTION OF THE RENT PAYMENTS FROM BVD CONSTITUTES UNRELATED BUSINESS INCOME TO SIMR UNDER SECTION 512(B)(13). AS OF 6/30/2024, THIS SUBLEASE WAS MODIFIED AND BVD NOW LEASES DIRECTLY FROM SREHC.
Schedule R, Part V Line 2 - Type B - CONTRIBUTION TO RELATED ORGANIZATIONSIMR CONTRIBUTED LEASEHOLD IMPROVEMENTS TO SREHC WHICH WERE PLACED INTO SERVICE DURING THE TAX YEAR.
Schedule R, Part V Line 2 - Type C - CONTRIBUTION From RELATED ORGANIZATIONSRM PROVIDED FINANCIAL SUPPORT TO SIMR TO BE USED BY SIMR IN FURTHERANCE OF SIMR'S EXEMPT PURPOSE OF CONDUCTING MEDICAL RESEARCH.
Schedule R, Part V Line 2 - TYPE K - LEASE FROM RELATED ORGANIZATIONSIMR ENTERED INTO A LEASE EFFECTIVE JANUARY 1, 2009 WITH SREHC, A 501(C)(2) TAX EXEMPT ORGANIZATION THAT IS A RELATED PARTY TO SIMR. THE LEASE HAS AN ORIGINAL TERM OF 10 YEARS WITH A PROVISION FOR ADDITIONAL OPTION YEARS FOR A 280,000 SQUARE FEET BUILDING. DURING THE TAX YEAR, FACILITIES IN THE AMOUNT OF $2,685,883 WERE DONATED TO SIMR FROM SREHC.
Schedule R, Part V Line 2 - TYPE P - REIMBURSEMENT TO RELATED ORGANIZATIONSIMR REIMBURSED SRM FOR COSTS ASSOCIATED WITH SRM'S ADMINISTRATIVE AND SUPPORT SERVICES PROVIDED TO SIMR. SRM IS A SUPPORTING ORGANIZATION TO SIMR.
Schedule R, Part V Line 2 - TYPE P - REIMBURSEMENT TO RELATED ORGANIZATIONSIMR REIMBURSED GSSIMR FOR CERTAIN STUDENT EXPENSES INCURRED DURING TIME SPENT IN SIMR LABS.
Schedule R, Part V Line 2 - TYPE Q - REIMBURSEMENT FROM RELATED ORGANIZATIONBVD REIMBURSED SIMR FOR SERVICES ON THE SERVICE COST METHOD.
Schedule R, Part V Line 2 - TYPE R - OTHER TRANSFER TO RELATED ORGANIZATIONEACH ACADEMIC YEAR, SIMR PROVIDES GSSIMR WITH AN APPROPRIATION PURSUANT TO AN AMOUNT AGREED UPON BY SIMR AND GSSIMR. SIMR PROVIDES GSSIMR THE PER CAPITA APPROPRIATION OF $2,595,150 AND SUPPLEMENTAL APPROPRIATION OF $210,000 FOR THE TOTAL $2,805,150.
Schedule R, Part V, Line 2 ALL OTHER TRANSACTIONSALL OTHER TRANSACTIONS FOR LINE 1 WERE BETWEEN 501(C)(3) PUBLIC CHARITIES AND BELOW REPORTING THRESHOLDS.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.